PDR MEMBER LOGIN:
  • Required field
  • Generic Name: (tesamorelin)
    Other Brands: N/A
  • Last Revised: 01/2015
    • What is this medication and its most common uses?

      Egrifta is a medicine used to reduce excessive abdominal (stomach area) fat in people with HIV-infection. Egrifta is administered subcutaneously (just below the skin).

    • What should I know when beginning and continuing on this medication?

      How does this medication work?

      Egrifta is thought to work with your own body to produce natural growth hormone to reduce your excess fat.

      What are the beneficial effects of this medication and when should I begin to have results?

      What: In clinical trials, Egrifta has been shown to reduce abdominal fat tissue by an average of 14-18%.

      When: Everyone responds differently to treatment, so try to be patient and follow your healthcare provider's directions. It is important that you use Egrifta exactly as your healthcare provider has prescribed.

      How do I know it is working?

      You may notice an improvement in the appearance of your abdominal area. This is a good indication that Egrifta is working.

    • What are the possible side effects of this medication?

      The following is not a full list of side effects. Side effects cannot be anticipated. If any develop or change in intensity, tell your healthcare provider as soon as possible. Only your healthcare provider can determine if it is safe for you to continue taking this medication.

      More common side effects may include: joint pain, injection-site redness or itching, pain or swelling in your arms or legs, muscle pain.

      Less common side effects may include:

      Serious allergic reactions with symptoms such as a rash, hives, swelling of your face or throat, shortness of breath or trouble breathing, fast heartbeat, or feeling of faintness or fainting.

      Egrifta may also increase your blood sugar levels.

    • Who should not take this medication?

      Do not use Egrifta if you are allergic to it or any of its ingredients.

      Do not use Egrifta if you have cancer (either newly diagnosed or recurrent) or are receiving treatment for cancer.

      Do not use Egrifta if you have a pituitary gland tumor, pituitary gland surgery, or other problems related to your pituitary gland.

      Do not use Egrifta if you are pregnant.

    • What should I tell my healthcare provider before I take the first dose of this medication?

      Tell your healthcare provider about all prescription, over-the-counter, and herbal medications you are taking before beginning treatment with Egrifta. Also, talk to your healthcare provider about your complete medical history, especially if you have diabetes, kidney or liver problems, have or have had cancer, or if you are pregnant, plan to become pregnant, or are breastfeeding.

    • What is the usual dosage?

      The information below is based on the dosage guidelines your healthcare provider uses. Depending on your condition and medical history, your healthcare provider may prescribe a different regimen. Do not change the dosage or stop taking your medication without your healthcare provider's approval.

      Adults: The recommended dose is 2 milligrams once a day.

    • How should I take this medication?

      Use Egrifta exactly as prescribed by your healthcare provider. Do not use extra doses or stop using it without first talking to your healthcare provider.

      Your healthcare provider will give you instructions on how to prepare and inject Egrifta.

      Inject Egrifta under the skin of your stomach area. Do not inject Egrifta into scar tissue, bruises, or your navel (belly button). Every time you inject Egrifta, rotate the injection site.

      Once you mix Egrifta, use it right away and throw away any unused medicine. Do not store mixed Egrifta.

      Please review the instructions that came with your prescription on how to properly inject Egrifta.

    • What should I avoid while taking this medication?

      Do not use Egrifta until your healthcare provider shows you how to use it correctly.

      Do not use Egrifta if the solution is cloudy, discolored, or has particles in it after mixing.

      Do not miss any scheduled follow-up appointments with your healthcare provider.

      Do not share needles or syringes with other people. Sharing of needles can result in the spread of HIV infection to others.

    • What are the possible food and drug interactions associated with this medication?

      If Egrifta is used with certain other drugs, the effects of either could be increased, decreased, or altered. Egrifta may interact with numerous medications. Therefore, it is very important that you tell your healthcare provider about any other medications you are taking.

    • May I receive this medication if I am pregnant or breastfeeding?

      Do not become pregnant while you are using Egrifta. The effects of Egrifta during breastfeeding are unknown. Tell your healthcare provider immediately if you are pregnant, plan to become pregnant, or are breastfeeding.

      The Centers for Disease Control and Prevention recommend that HIV- infected mothers not breastfeed their infants to avoid risking transmission of the virus to the child.

    • What should I do if I miss a dose of this medication?

      If you miss a dose of Egrifta, use it as soon as you remember. However, if it is almost time for your next dose, skip the one you missed and return to your regular dosing schedule. Do not use two doses at once.

    • How should I store this medication?

      Store Egrifta in the refrigerator. Protect from light.

      Store sterile water for injection, syringes, and needles at room temperature.

    • Who should I contact in case of emergency or overdose?
      back to top

      In the event of a medical emergency call your doctor or 9-1-1 immediately. In the event of overdose, call your doctor or poison control for further instructions.
      National Poison Control#: Call 1-800-222-1222

      This PDR+ drug information has been developed by the Physicians’ Desk Reference Network (PDRN), a source of medication information trusted by doctors for over 65 years.

      This monograph summarizes the most important information about your medication and does not cover all the information you may need. If you have any questions or concerns or want to learn more about your medication, ask your healthcare provider; he/she will be able to provide answers to your questions. This medication should only be used by the patient for whom it was prescribed and should not be shared with other people.
    • Additional patient resources.
      back to top Use your PDR® Pharmacy Discount Card when you or a family member fills a prescription and ask for your PDR® Discount every
      time!
  •  
  • Terms of Service

    This discount plan is NOT insurance or a Medicare prescription drug plan. The plan is not intended as a substitute for insurance and does not meet creditable coverage requirements under state or federal law. The plan provides discounts at participating pharmacies on certain pharmaceutical supplies, prescription drugs, or medical equipment and supplies. The range of discounts will vary depending on the products received. Members are obligated to pay the pharmacy the entire amount of the discounted rate for such products at the point of sale. The plan does not pay pharmacies for products provided to members. No enrollment or periodic fees apply. The pharmacy may pay the plan a fee from amounts the pharmacy collects from the member. The discount plan organization is ProCare Pharmacy Benefit Manager, Inc.,1267 Professional Parkway, ProCare Office Park, Gainesville, GA 30507, 1-888-299-5383. Customer service is provided by PDR, LLC., 5 Paragon Drive, Montvale, NJ, 07645, 1-800-232-7379, www.pdr.net/DiscountCard, customerservice@pdr.net.